Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: The role of μ-calpain

Diabetes

Volumn 56, Issue 7, 2007, Pages 1842-1849

  Scalia, Rosario ^a   Gong, Yulan ^a   Berzins, Brett ^a   Li, Juan Zhao ^a   Sharma, Kumar ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALPAIN; MU CALPAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LEUKOCYTE ADHERENCE; MALE; MICROCIRCULATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; ZUCKER DIABETIC FATTY RAT;

ALBUMINS; ANIMALS; CALPAIN; CAPILLARY PERMEABILITY; DIABETES MELLITUS, TYPE 2; DIPEPTIDES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERGLYCEMIA; LEUKOCYTES; MALE; MICROCIRCULATION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, ZUCKER; VASCULAR DISEASES;

EID: 34347369727     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1198     Document Type: Article

References (50)

1. Dandona P, Aljada A, Chaudhuri A, Mohanty P: Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord 5:189-197, 2004
2. Lteif AA, Han K, Mather KJ: Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112:32-38, 2005
3. Dang L, Seale JP, Qu X: High glucose-induced human umbilical vein endothelial cell hyperpermeability is dependent on protein kinase C activation and independent of the Ca2+-nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 32:771-776, 2005
4. Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H, Ruther W, Hansen-Algenstaedt N: Microvascular alterations in diabetic mice correlate with level of hyperglycemia. Diabetes 52:542-549, 2003
5. Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E: Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48:2052-2058, 1999
6. Plante GE, Chakir M, Lehoux S, Lortie M: Disorders of body fluid balance: a new look into the mechanisms of disease. Can J Cardiol 11:788-802, 1995
7. Basi S, Lewis JB: Microalbuminuria as a target to improve cardiovascular and renal outcomes. Am J Kidney Dis 47:927-946, 2006
8. Goll DE, Thompson VF, Li H, Wei W, Cong J: The calpain system. Physiol Rev 83:731-801, 2003
9. Stalker TJ, Gong Y, Scalia R: The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 54:1132-1140, 2005
10. Stalker TJ, Skvarka CB, Scalia R: A novel role for calpains in the endothelial dysfunction of hyperglycemia. FASEB J 17:1511-1513, 2003
11. Nangle MR, Cotter MA, Cameron NE: The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice. Eur J Pharmacol 538:148-153, 2006
12. Terada M, Yasuda H, Kikkawa R: Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J Neurol Sci 155:23-30, 1998
13. McDonald MC, Mota-Filipe H, Paul A, Cuzzocrea S, Abdelrahman M, Harwood S, Plevin R, Chatterjee PK, Yaqoob MM, Thiemermann C: Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock. FASEB J 15:171-186, 2001
14. Bernhard D, Csordas A, Henderson B, Rossmann A, Kind M, Wick G: Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J 19:1096-1107, 2005
15. Gonscherowski V, Becker BF, Moroder L, Motrescu E, Gil-Parrado S, Gloe T, Keller M, Zahler S: Calpains: a physiological regulator of the endothelial barrier? Am J Physiol Heart Circ Physiol 290:H2035-H2042, 2006
16. Peterson RG: The zucker diabetic fatty (ZDF) rat. In Animal Models of Diabetes: A Primer. Sharif E, Ed. Newark, NJ, Hardwood Academic Publisher, 2001, p. 109-128
17. St-Pierre P, Bouffard L, Papirakis ME, Maheux P: Increased extravasation of macromolecules in skeletal muscles of the Zucker rat model. Obesity 14:787-793, 2006
18. Bohlen HG, Hankins KD: Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats. Diabetologia 22:344-348, 1982
19. Booth G, Stalker TJ, Lefer AM, Scalia R: Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 280:E848-E856, 2001
20. Smith ML, Long DS, Damiano ER, Ley K: Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys J 85:637-645, 2003
21. De Vriese AS, Tilton RG, Stephan CC, Lameire NH: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 12:1734-1741, 2001
22. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN: Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 74:336-343, 1994
23. Guttmann RP, Johns RA: Measurement of calpain activity in vitru and in situ using a fluorescent compund and tau as substrates. In Calpain Methods and Protocols John SE, Ed. Totowa, NJ, Humana Press, 2000, p. 143-150
24. Sultan KR, Dittrich BT, Pette D: Calpain activity in fast, slow, transforming, and regenerating skeletal muscles of rat. Am J Physiol Cell Physiol 279:C639-C647, 2000
25. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S: Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (Tokyo) 119:572-576, 1996
26. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, Kubes P: Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103:1269-1276, 1999
27. Fujitani K, Kambayashi J, Sakon M, Ohmi SI, Kawashima S, Yukawa M, Yano Y, Miyoshi H, Ikeda M, Shinoki N, Monden M: Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells. J Cell Biochem 66:197-209, 1997
28. Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN: Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93:161-167, 1996
29. Wedmore CV, Williams TJ: Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289:646-650, 1981
30. Tangelder GJ, Janssens CJ, Slaaf DW, oude Egbrink MG, Reneman RS: In vivo differentiation of leukocytes rolling in mesenteric postcapillary venules. Am J Physiol 268:H909-H915, 1995
31. Goodarzi MO, Taylor KD, Guo X, Quinones MJ, Cui J, Li Y, Saad MF, Yang H, Hsueh WA, Hodis HN, Rotter JI: Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study. Diabetes 54:1228-1232, 2005
32. Paulhe F, Bogyo A, Chap H, Perret B, Racaud-Sultan C: Vascular smooth muscle cell spreading onto fibrinogen is regulated by calpains and phospholipase C. Biochem Biophys Res Commun 288:875-881, 2001
33. Croce K, Flaumenhaft R, Rivers M, Furie B, Furie BC, Herman IM, Potter DA: Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 274:36321-36327, 1999
34. Dnyanmote AV, Sawant SP, Lock EA, Latendresse JR, Warbritton AA, Mehendale HM: Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes. Toxicol Appl Pharmacol 215:146-157, 2006
35. Parving HH, Noer I, Deckert T, Evrin PE, Nielsen SL, Lyngsoe J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA: The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12:161-166, 1976
36. Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW, Penn State Retina Research Group: Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47:1953-1959, 1998
37. Pinter GG, Lightman SL, Wilson PD, Yuen L, Bradbury MW: Albumin escape from microvessels in kidney, heart and skeletal muscle in experimental diabetes mellitus in the anaesthetized rat. Exp Physiol 76:899-904, 1991
38. Arshi K, Bendayan M, Ghitescu LD: Alterations of the rat mesentery vasculature in experimental diabetes. Lab Invest 80:1171-1184, 2000
39. Lawson S, Ward DT, Conner C, Gallagher C, Tsokos G, Shea-Donohue T: Diabetic hyperglycemia: a facilitating factor in systemic capillary leak. J Surg Res 105:95-101, 2002
40. Huxley V, Rumbaut RE: Microvascular permeability in inflammation. In Physiology of Inflammation. Ley K, Ed. New York, Oxford University Press, 2001, p. 65-79
41. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G: Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 101:1905-1915, 1998
42. Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, Sydow K, Lau D, Szocs K, Klinke A, Kubala L, Berglund L, Schrepfer S, Deuse T, Haddad M, Risius T, Klemm H, Reichenspurner HC, Meinertz T, Heitzer T: Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113:1871-1878, 2006
43. Mehta D, Malik AB: Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279-367, 2006
44. Yuan SY, Ustinova EE, Wu MH, Tinsley JH, Xu W, Korompai FL, Taulman AC: Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 87:412-417, 2000
45. Park JY, Ha SW, King GL: The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int 19 (Suppl. 2):S222-S227, 1999
46. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
47. Sato K, Kawashima S: Calpain function in the modulation of signal transduction molecules. Biol Chem 382:743-751, 2001
48. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB: Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289:L371-L381, 2005
49. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219-226, 1989
50. Ritz E: Renal dysfunction as a novel risk factor: microalbuminuria and cardiovascular risk. Kidney Int 93:S25-S28, 2005